Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Cancer (Print)

Results: 51-75/7750

Authors: Maitra, A Rathi, A Gazdar, AF Sagalowsky, A Ashfaq, R
Citation: A. Maitra et al., Expression of the RNA component of human telemorase (hTR) in ThinPrep (R) preparations from bladder washings, CANC CYTOP, 93(1), 2001, pp. 73-79

Authors: Pollock, RE
Citation: Re. Pollock, Note from the editor-in-chief, CANCER, 92(9), 2001, pp. 2235-2236

Authors: Sillos, EM Shenep, JL Burghen, GA Pui, CH Behm, FG Sandlund, JT
Citation: Em. Sillos et al., Lactic acidosis: A metabolic complication of hematologic malignancies - Case report and review of the literature, CANCER, 92(9), 2001, pp. 2237-2246

Authors: Bonneterre, J Buzdar, A Nabholtz, JMA Robertson, JFR Thurlimann, B von Euler, M Sahmoud, T Webster, A Steinberg, M
Citation: J. Bonneterre et al., Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma - Results of two randomized trials designed for combined analysis, CANCER, 92(9), 2001, pp. 2247-2258

Authors: Georgiannos, SN Aleong, JC Goode, AW Sheaff, M
Citation: Sn. Georgiannos et al., Secondary neoplasms of the breast - A survey of the 20th century, CANCER, 92(9), 2001, pp. 2259-2266

Authors: Zelek, L Barthier, S Riofrio, M Fizazi, K Rixe, O Delord, JP Le Cesne, A Spielmann, M
Citation: L. Zelek et al., Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma, CANCER, 92(9), 2001, pp. 2267-2272

Authors: Bellantone, R Lombardi, CP Bossola, M Ferrante, A Princi, P Boscherini, M Maussier, L Salvatori, M Rufini, V Reale, F Romano, L Tallini, G Zelano, G Pontecorvi, A
Citation: R. Bellantone et al., Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies accordingto the histologic type - Results of a prospective study, CANCER, 92(9), 2001, pp. 2273-2279

Authors: Abou-Rebyeh, H Borgmann, V Nagel, R Al-Abadi, H
Citation: H. Abou-rebyeh et al., DNA ploidy is a valuable predictor for prognosis of patients with resectedrenal cell carcinoma, CANCER, 92(9), 2001, pp. 2280-2285

Authors: Buzio, C Andrulli, S Santi, R Pavone, L Passalacqua, R Potenzoni, D Ferrozzi, F Giacosa, R Vaglio, A
Citation: C. Buzio et al., Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinoma, CANCER, 92(9), 2001, pp. 2286-2296

Authors: Coffey, RNT Watson, RWG Hegarty, PK Watson, CL Wolohan, L Brady, HR O'Keane, C Fitzpatrick, JM
Citation: Rnt. Coffey et al., Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases, CANCER, 92(9), 2001, pp. 2297-2308

Authors: Demers, RY Tiwari, A Wei, J Weiss, LK Severson, RK Montie, J
Citation: Ry. Demers et al., Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality, CANCER, 92(9), 2001, pp. 2309-2317

Authors: Fairfield, KM Hankinson, SE Rosner, BA Hunter, DJ Colditz, GA Willett, WC
Citation: Km. Fairfield et al., Risk of ovarian carcinoma and consumption of vitamins A, C, and E and specific carotenoids - A prospective analysis, CANCER, 92(9), 2001, pp. 2318-2326

Authors: Verschraegen, CF Kavanagh, JJ Loyer, E Bodurka-Bevers, D Kudelka, AP Hu, W Vincent, M Nelson, T Levenback, C
Citation: Cf. Verschraegen et al., Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix, CANCER, 92(9), 2001, pp. 2327-2333

Authors: Clark, JI Hofmeister, C Choudhury, A Matz, G Collins, S Bastian, R Melian, E Emami, B Petruzzelli, G
Citation: Ji. Clark et al., Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma, CANCER, 92(9), 2001, pp. 2334-2340

Authors: Hollenbeak, CS Lowe, VJ Stack, BC
Citation: Cs. Hollenbeak et al., The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the NO neck, CANCER, 92(9), 2001, pp. 2341-2348

Authors: Jiang, WW Fujii, H Shirai, T Mega, H Takagi, M
Citation: Ww. Jiang et al., Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity, CANCER, 92(9), 2001, pp. 2349-2356

Authors: Lam, WMM Leung, SF So, NMC Wong, KS Liu, KH Ku, PKM Yuen, HY Metreweli, C
Citation: Wmm. Lam et al., Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy, CANCER, 92(9), 2001, pp. 2357-2363

Authors: Tseng, JE Glisson, BS Khuri, FR Shin, DM Myers, JN El-Naggar, AK Roach, JS Ginsberg, LE Thall, PF Wang, XM Teddy, S Lawhorn, KN Zentgraf, RE Steinhaus, GD Pluda, JM Abbruzzese, JL Hong, WK Herbst, RS
Citation: Je. Tseng et al., Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck, CANCER, 92(9), 2001, pp. 2364-2373

Authors: Okabayashi, T Yamamoto, J Kosuge, T Shimada, K Yamasaki, S Takayama, T Makuuchi, M
Citation: T. Okabayashi et al., A new staging system for mass-forming intrahepatic cholangiocarcinoma - Analysis of preoperative and postoperative variables, CANCER, 92(9), 2001, pp. 2374-2383

Authors: Wakabayashi, H Ishimura, K Okano, K Izuishi, K Karasawa, Y Goda, F Maeba, T Maeta, H
Citation: H. Wakabayashi et al., Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma?, CANCER, 92(9), 2001, pp. 2384-2390

Authors: Hainsworth, JD Burris, HA Billings, FT Bradof, JE Baker, M Greco, FA
Citation: Jd. Hainsworth et al., Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma - Phase II trials of the Minnie Pearl Cancer Research Network, CANCER, 92(9), 2001, pp. 2391-2398

Authors: Kasuga, I Makino, S Kiyokawa, H Katoh, H Ebihara, Y Ohyashiki, K
Citation: I. Kasuga et al., Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma, CANCER, 92(9), 2001, pp. 2399-2405

Authors: Pan, CC Chen, PCH Wang, LS Chi, KH Chiang, H
Citation: Cc. Pan et al., Thymoma is associated with an increased risk of second malignancy, CANCER, 92(9), 2001, pp. 2406-2411

Authors: Morice, P Wicart-Poque, F Rey, A El-Hassan, J Pautier, P Lhomme, C de Crevoisier, R Haie-Meder, C Duvillard, P Castaigne, D
Citation: P. Morice et al., Results of conservative treatment in epithelial ovarian carcinoma, CANCER, 92(9), 2001, pp. 2412-2418

Authors: Banfi, A Podesta, M Fazzuoli, L Sertoli, MR Venturini, M Santini, G Cancedda, R Quarto, R
Citation: A. Banfi et al., High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors - A mechanism for post-bone marrow transplantation osteopenia, CANCER, 92(9), 2001, pp. 2419-2428
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>